• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-07-31

  This study identifies quercetin as a potent modulator of the Hippo signaling pathway in cataractogenesis. Through in vivo and in vitro models, it demonstrates that quercetin suppresses Hippo pathway activation, reduces oxidative stress, and promotes lens epithelial cell survival, offering mechanistic insight for non-surgical cataract interventions.

• Cediranib (AZD2171): Precision in VEGFR Inhibition for Cance

  2026-07-31

  This article explores real laboratory challenges in cell viability and signaling assays, showing how Cediranib (AZD2171, SKU A1882) offers robust, data-backed solutions for angiogenesis and tumor biology research. Scenarios address protocol optimization, data interpretation, and product selection, giving biomedical scientists actionable, evidence-based insights.

• Applied Workflows with Nicotinamide Adenine Dinucleotide (NA

  2026-07-30

  Harness the versatility of Nicotinamide Adenine Dinucleotide (NAD+) for advanced metabolic signaling and DNA damage response assays. This article delivers stepwise protocols, troubleshooting tactics, and expert translation of the latest bench research—empowering researchers to optimize autophagy and stress adaptation studies using APExBIO’s high-purity NAD+.

• Weight Loss Restores Intestinal Stretch-Mediated Satiety in

  2026-07-30

  This study reveals that intestinal stretch acutely suppresses food intake and improves glucose tolerance independently of GLP-1 signaling, but these effects are blunted in obesity and restored following weight loss. The findings highlight a GLP-1-independent mechanosensory pathway regulating satiety and glucose homeostasis, with significant implications for type II diabetes treatment research.

• Applied ddhCTP: Inhibiting RNA Virus Replication in Antivira

  2026-07-29

  ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) empowers antiviral researchers with a direct, mechanism-driven tool for halting RNA virus replication in vitro and in cellular models. This article distills the latest experimental workflows, troubleshooting insights, and protocol refinements based on recent mechanistic breakthroughs—enabling robust and reproducible antiviral assays.

• SB743921: Advanced Kinesin Spindle Protein Inhibitor Workflo

  2026-07-29

  SB743921 stands out as a potent, selective kinesin spindle protein inhibitor, empowering cancer researchers to achieve nanomolar-level precision in cell cycle arrest and anti-proliferative assays. This article bridges protocol enhancements, troubleshooting, and translational insights, drawing on recent methodological advances and a pivotal reference study.

• EZ Cap™ Firefly Luciferase mRNA: Stable Reporter for mRNA As

  2026-07-28

  EZ Cap™ Firefly Luciferase mRNA provides a robust, Cap 1-optimized tool for gene regulation and in vivo bioluminescent assays. Its enhanced stability and translational efficiency enable reproducible quantification in mRNA delivery and translation efficiency studies. Designed for research, this product addresses key bottlenecks in molecular biology workflows.

• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-07-28

  This study identifies quercetin as a potent protective agent against cataract development, acting through modulation of the Hippo signaling pathway. By combining network pharmacology with in vivo and in vitro analyses, the research demonstrates that Hippo pathway inactivation by quercetin enhances lens epithelial cell survival and proliferation, providing a mechanistic basis for future pharmacological interventions.

• Differential Fgf10/Fgfr2 Expression Shapes Penile Developmen

  2026-07-27

  Wang and Zheng's 2025 study reveals that species-specific differences in penile development between guinea pigs and mice are governed by the differential expression of Shh, Fgf10, and Fgfr2. Their comparative analysis provides new mechanistic insight into urethral groove and prepuce formation, with implications for developmental biology and disease modeling.

• DNase I (RNase-free): Optimized DNA Removal for RNA Assays

  2026-07-27

  DNase I (RNase-free) from APExBIO is an essential tool for eliminating contaminating DNA in RNA extraction and RT-PCR, ensuring high-quality, reproducible results. Discover protocol enhancements, troubleshooting strategies, and translational insights inspired by cutting-edge cancer research.

• Gene Expression Profiling Predicts Olaparib Response in Meso

  2026-07-26

  Borchert et al. (2019) identified that gene expression signatures indicative of homologous recombination repair (HRR) deficiency—termed 'BRCAness'—correlate with increased susceptibility to PARP inhibitor therapy in malignant pleural mesothelioma (MPM) cell lines. Their findings provide a rationale for stratifying MPM patients by HRR status and inform the design of targeted combination therapies.

• Pemetrexed Disodium in Cancer Research: Protocols & Insights

  2026-07-25

  Pemetrexed, a multi-targeted antifolate antimetabolite, empowers cancer chemotherapy research with reproducible workflows and mechanistic precision. Discover advanced protocols, troubleshooting strategies, and novel insights for leveraging pemetrexed disodium in both in vitro and in vivo tumor models.

• Magnetite-Coated Cellulose Nanocrystals for Magnetic Hyperth

  2026-07-24

  This study systematically investigates how the surface chemistry of cellulose nanocrystals (CNCs) governs their interactions with magnetite nanoparticles and influences performance in magnetic hyperthermia. Findings reveal that CNC functionalization modulates nanocomposite structure, magnetization, and biocompatibility, providing a robust framework for designing safe and effective nanomaterials for biomedical applications.

• Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model

  2026-07-24

  This study uncovers how Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively suppresses triple-negative breast cancer (TNBC) by inducing ferroptosis through the CUL3–MTDH ubiquitination pathway. The findings offer a mechanistic rationale for leveraging Gramine in ferroptosis and ubiquitination-focused cancer biology research workflows.

• Nifedipine (BAY-a-1040): Mechanisms, Evidence & Research Uti

  2026-07-23

  Nifedipine (BAY-a-1040) is a potent, selective L-type calcium channel blocker used in research to inhibit calcium influx and study calcium-dependent cellular processes. It also modulates iron metabolism and demonstrates antifungal effects. APExBIO provides high-purity, research-grade Nifedipine for advanced experimental workflows.

8695 records 4/580 page Previous Next 12345 下5页 Last page